Circassia Pharmaceuticals (CIR) Pharma and Biotech Sector

  • Latest quote

    58.20p (mid)

  • Current Change (%)

    0.00%

  • Price

    Bid: 56.40p

    Offer: 58.60p

  • Today

    High: 58.24p

    Low: 58.20p

  • This year

    High: 104.00p

    Low: 48.05p

  • Information

    Volume: 4,035

    Market Cap: £209.2M



Circassia Pharmaceuticals Overview

Circassia is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Circassia Pharmaceuticals RNS Feed

Title Release date
Listing Rule 9.6.14(R) Disclosure 07:00 - December 17, 2018
Option exercised for Tudorza from AstraZeneca 12:10 - December 11, 2018
Posting of Shareholder Circular 17:59 - December 10, 2018
Proposed admission to trading on AIM 12:59 - December 10, 2018
Total Voting Rights 07:00 - November 30, 2018
Total Voting Rights 14:13 - October 31, 2018
Holding(s) in Company 15:00 - October 25, 2018
Notice of Interim Results and Broker Appointment 11:36 - September 7, 2018
Total Voting Rights 12:15 - September 3, 2018
Director Declaration 16:25 - August 16, 2018
Regulatory Application 07:00 - August 13, 2018
Total Voting Rights 07:00 - July 31, 2018
Holding(s) in Company 16:14 - July 18, 2018
Holding(s) in Company 16:12 - July 18, 2018
Issue of Equity and Total Voting Rights 13:52 - July 18, 2018

NOTE: This is based on 30 open tips for this company


Total Number of Share tips :

35

View all Circassia Pharmaceuticals Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today